4//SEC Filing
ISIS PHARMACEUTICALS INC 4
Accession 0000874015-07-000062
$IONSCIK 0000874015operating
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 5:09 PM ET
Size
9.8 KB
Accession
0000874015-07-000062
Insider Transaction Report
Form 4
Treble Michael J
Vice President
Transactions
- Exercise/Conversion
Common Stock
2007-09-14$5.95/sh+10,000$59,500→ 10,000 total - Exercise/Conversion
Employee Stock Option (right to buy)
2007-09-14−10,000→ 41,875 totalExercise: $5.95From: 2005-12-06Exp: 2011-12-05→ Common Stock (10,000 underlying) - Sale
Common Stock
2007-09-14$13.96/sh−10,000$139,600→ 0 total
Footnotes (3)
- [F1]The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 1/12/07.
- [F2]The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 1/12/07.
- [F3]Stock option under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 12/6/05. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 22,500 shares per year. The option was exercisable as to 51,875 shares on 9/14/07 prior to the reported exercise.
Documents
Issuer
ISIS PHARMACEUTICALS INC
CIK 0000874015
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0000874015
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 5:09 PM ET
- Size
- 9.8 KB